-transparent.png){kind=logo}
To evaluate the role of p16 multiple tumor suppressor (MTS1) and p53 protein in human radiation-induced skin cancer, we examined the expression of p16 and p53 in eight cases using immunohistochemistry. An abnormal location of p16 expression in the cytoplasm was found in seven of eight cases, but the expression of p53 in nuclei was noted in only three of eight cases. These findings suggest that the inactivation of p16 might be related to its binding with another unknown oncoprotein in the cytoplasm and thus lead to carcinogenesis.
Related Publications
P Zhao, and
D W Wang, and
G Li, and
Y Gao, and
X Li
December 1991,
Cancer research,
P Zhao, and
D W Wang, and
G Li, and
Y Gao, and
X Li
July 1992,
The American journal of pathology,
P Zhao, and
D W Wang, and
G Li, and
Y Gao, and
X Li
January 1998,
Anticancer research,
P Zhao, and
D W Wang, and
G Li, and
Y Gao, and
X Li
May 1994,
Gan to kagaku ryoho. Cancer & chemotherapy,
P Zhao, and
D W Wang, and
G Li, and
Y Gao, and
X Li
February 1993,
Human genetics,
P Zhao, and
D W Wang, and
G Li, and
Y Gao, and
X Li
December 2010,
Cell cycle (Georgetown, Tex.),
P Zhao, and
D W Wang, and
G Li, and
Y Gao, and
X Li
January 1996,
Dermatology (Basel, Switzerland),
P Zhao, and
D W Wang, and
G Li, and
Y Gao, and
X Li
June 2012,
Medical molecular morphology,
P Zhao, and
D W Wang, and
G Li, and
Y Gao, and
X Li
September 2009,
Journal of cellular and molecular medicine,
P Zhao, and
D W Wang, and
G Li, and
Y Gao, and
X Li
January 1997,
Radiation oncology investigations,
